Comment on: A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis
- PMID: 35655032
- DOI: 10.1007/s00270-022-03172-5
Comment on: A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis
Comment on
-
A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis.Cardiovasc Intervent Radiol. 2022 Aug;45(8):1102-1113. doi: 10.1007/s00270-022-03116-z. Epub 2022 Mar 30. Cardiovasc Intervent Radiol. 2022. PMID: 35355094
References
-
- Nguyenhuy M, Xu Y, Maingard J, Barnett S, Kok HK, Brooks M, et al. A systematic review and meta-analysis of patient survival and disease recurrence following percutaneous ablation of pulmonary metastasis. Cardiovasc Intervent Radiol. 2022. https://doi.org/10.1007/s00270-022-03116-z . - DOI - PubMed
-
- Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, et al. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients—control survival is much better than previously assumed. Colorectal Dis. 2020;22(10):1314–24. - DOI
-
- Treasure T, Farewell V, Macbeth F, Batchelor T, Milosevic M, King J, et al. The Pulmonary Metastasectomy in Colorectal Cancer cohort study: analysis of case selection, risk factors and survival in a prospective observational study of 512 patients. Colorectal Dis. 2021;23(7):1793–803. - DOI
-
- Macbeth F, Farewell V, Treasure T. RE: Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(10):29117361. https://doi.org/10.1093/jnci/djx149 . - DOI
-
- Macbeth F, Treasure T. Points to consider regarding the SABR-COMET trial. Lancet. 2020;395(10222):e19. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical